Neurology Evidence

Section 1: Ischemic Stroke
Authors: Mark Etherton, Jesse Thon
Senior Author: Steven K. Feske
Chapter 1: Intravenous tPA for acute ischemic stroke
Chapter 2: Aspirin for secondary stroke prevention
Chapter 3: Mechanical thrombectomy for large vessel occlusion
Chapter 4: Harm from stenting of symptomatic intracranial arterial stenoses
Chapter 5: Warfarin for atrial fibrillation
Chapter 6: Novel oral anticoagulants for stroke prevention in non-valvular atrial fibrillation
Chapter 7: Intense low-density lipoprotein cholesterol reduction for stroke prevention
Chapter 8: Marginal benefit from device closure of patent foramen ovale
Chapter 9: Early decompressive surgery in malignant infarction of the middle cerebral artery
Chapter 10: Carotid endarterectomy for stroke prevention in internal carotid artery stenosis
Chapter 11: Carotid artery stenting versus carotid endarterectomy for symptomatic and asymptomatic carotid artery stenosis
Chapter 12: Warfarin and aspirin in patients with heart failure and sinus rhythm
Chapter 13: Short-term dual antiplatelet therapy for stroke prevention after TIA or minor stroke
Chapter 14: Aspirin over warfarin for symptomatic intracranial stenosis
Chapter 15: Lack of benefit from long-term dual antiplatelet therapy for secondary stroke prevention
Chapter 16: Fluoxetine for motor recovery after acute ischemic stroke
Chapter 17: Carotid endarterectomy for asymptomatic carotid artery stenosis
Chapter 18: Extended monitoring for paroxysmal atrial fibrillation
Chapter 19: The National Institutes of Health Stroke Scale

Section 2: Cerebral Hemorrhage
Authors: David J. Lin, Saad Mir
Senior Author: Stephen M. Greenberg
Chapter 20: Blood pressure regulation in parenchymal intracerebral hemorrhage
Chapter 21: Early surgery for spontaneous intracerebral hemorrhage and hydrocephalus
Chapter 22: Avoidance of long-term anticoagulation for atrial fibrillation after intracerebral hemorrhage
Chapter 23: Nimodipine for prevention of delayed neurologic injury after subarachnoid hemorrhage
Chapter 24: Inferiority of surgical resection to medical management of unruptured AVM
Chapter 25: Prognostication for intracerebral hemorrhage
Chapter 26: Acute endovascular treatment for ruptured subarachnoid hemorrhage
Chapter 27: Neurosurgical clipping versus endovascular coiling of ruptured intracranial aneurysms
Chapter 28: Withdrawal of support in intracerebral hemorrhage due to predicted poor prognosis may lead to self-fulfilling prophecy
Chapter 29: rTPA for intraventricular hemorrhage
Chapter 30: Grading of ruptured subarachnoid hemorrhages

Section 3: Traumatic Brain Injury
Author: Daniel B. Rubin
Senior Author: Brian L. Edlow
Chapter 31: Glasgow Coma Scale
Chapter 32: Albumin versus saline for resuscitation after traumatic brain injury
Chapter 33: Decompressive craniectomy in traumatic brain injury
Chapter 34: Antiepileptic drugs after traumatic brain injury
Chapter 35: Intracranial pressure monitoring in traumatic brain injury
Chapter 36: Amantadine for recovery of consciousness after traumatic brain injury
Chapter 37: Functional imaging in vegetative states
Chapter 38: Corticosteroids for traumatic brain injury
Chapter 39: Corticosteroids in acute spinal cord injury

Section 4: Neurologic Intensive Care
Authors: David J. Lin
Senior Author: Henrikas Vaitkevicius
Chapter 40: Midline shift and level of consciousness
Chapter 41: Hyperosmolar therapy for intracranial pressure
Chapter 42: Hyperventilation for acute intracranial elevation
Chapter 43: Temperature management for cardiac arrest in adults
Chapter 44: Early mobilization in the intensive care unit

Section 5: Neuroinfectious Diseases
Author: Altaf Saadi
Senior Author:Jennifer Lyons
Chapter 45: Glucocorticoids for bacterial meningitis in adults
Chapter 46: Acyclovir for Herpes Simplex encephalitis
Chapter 47: Polymerase chain reaction testing for Herpes Simplex Encephalitis
Chapter 48: Antifungal therapy for Cryptococcal meningitis
Chapter 49: Guidelines for treatment of Lyme disease in the nervous system

Section 6: Neuro-oncology
Author: Maya Graham
Senior Author: Mikael Rinne
Chapter 50: Temozolomide for glioblastoma
Chapter 51: Surgery for brain metastases
Chapter 52: Chemotherapy for low-grade glioma
Chapter 53: NovoTTF for newly-diagnosed glioblastoma
Chapter 54: Bevacizumab for recurrent glioblastoma
Chapter 55: Methotrexate for primary CNS lymphoma

Section 7: Neuromuscular
Author: Kathleen McKee
Senior Author: Michael Bowley
Chapter 56: Acute treatment for Guillain-Barre syndrome
Chapter 57: Alternate day prednisone in myasthenia gravis
Chapter 58: IVIg vs. prednisone for chronic inflammatory demyelinating polyneuropathy
Chapter 59: Glucocorticoid steroids for Duchenne muscular dystrophy
Chapter 60: Riluzole in amyotrophic lateral sclerosis
Chapter 61: Thymectomy in myasthenia gravis

Section 8: Movement Disorders
Author: Abby Olsen
Senior Author: Todd Herrington
Chapter 62: L-dopa for Parkinson's disease
Chapter 63: Deep brain stimulation for Parkinson's disease
Chapter 64: Deep brain stimulation for dystonia
Chapter 65: L-dopa vs MAO-B inhibitors in Parkinson’s disease
Chapter 66: Propranolol treatment for essential tremor
Chapter 67: Rasagaline in Parkinson’s disease
Chapter 68: Botulin A toxin for dystonia

Section 9: Multiple Sclerosis
Author: Tamara Kaplan
Senior Author: James Stankiewicz
Chapter 69: Progressive multifocal leukoencephalopathy after treatment with natalizumab
Chapter 70: Glucocorticoids for optic neuritis: the optic neuritis treatment trial
Chapter 71: NMO antibody in the diagnosis of neuromyelitis optica
Chapter 72: Correlation between MRI findings and disability in multiple sclerosis
Chapter 73: The association of Vitamin D levels and multiple sclerosis
Chapter 74: Rate of pregnancy-related relapse in Multiple Sclerosis

Section 10: Autoimmune Neurology
Author: Christopher Doughty
Senior Author: Nagagopal Venna
Chapter 75: EULAR recommendations for treatment of primary CNS vasculitis
Chapter 76: NMDA-ab receptor encephalitis with ovarian teratoma
Chapter 77: Identification of Sjogren's ganglionopathy
Chapter 78: IVIG for stiff person syndrome

Section 11: Epilepsy
Author: Anna Bank
Senior Author: Brandon Westover
Chapter 79: Lorazepam for treatment of status epilepticus
Chapter 80: Magnesium for prevention of eclampsia
Chapter 81: Antiepileptic drug treatment after a first unprovoked seizure
Chapter 82: Intravenous vs intramuscular benzodiazepines for status epilepticus
Chapter 83: Continuous EEG monitoring for evaluation of nonconvulsive status epilepticus

Section 12: Headache & Pain
Author: Sheena Chew
Senior Author: William Mullally
Chapter 84: Sumatriptan for migraine
Chapter 85: Topiramate for migraine prevention
Chapter 86: Duloxetine for chemo-induced painful neuropathy
Chapter 87: Pregabalin for neuropathic pain
Chapter 88: Amitriptyline prophylaxis for headache
Chapter 89: Divalproex for migraine prophylaxis

Section 13: Cognitive Neurology
Author: Emer McGrath
Senior Author: Scott M. McGinnis
Chapter 90: Donepezil for Alzheimer's Disease
Chapter 91: Memantine in addition to donepezil for Alzheimer’s disease
Chapter 92: Rivastigmine for dementia with Lewy bodies
Chapter 93: Melatonin for REM sleep behavior disorder
Chapter 94: Agitation in dementia

Section 14: Pediatric Neurology
Author: Missy Walker
Senior Author: Patricia Musolino
Chapter 95: Treatment of infantile spasms
Chapter 96: Pharmaco vs behavioral therapy for ADHD
Chapter 97:: Ketogenic diet for treatment of childhood epilepsy
Chapter 98: Hypothermia for neonates with hypoxic-ischemic encephalopathy
Chapter 99: Febrile seizures
Chapter 100: When to Stop Antiepileptic drugs in children with epilepsy